Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LACC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC16A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00659 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HLF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MEF2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HORMAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2CD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLFN13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADARB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARHSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIFO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on